FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 169 filers reported holding FATE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 9.78 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $78,571 | -22.2% | 37,062 | +74.7% | 0.00% | – |
| Q2 2023 | $100,979 | -96.9% | 21,214 | -93.5% | 0.00% | -100.0% |
| Q4 2022 | $3,308,309 | -37.7% | 327,880 | +38.4% | 0.00% | -40.0% |
| Q3 2022 | $5,309,000 | -8.9% | 236,890 | +0.7% | 0.01% | 0.0% |
| Q2 2022 | $5,829,000 | -30.6% | 235,235 | +8.6% | 0.01% | -16.7% |
| Q1 2022 | $8,400,000 | -20.1% | 216,675 | +20.7% | 0.01% | -14.3% |
| Q4 2021 | $10,507,000 | +29.0% | 179,585 | +30.7% | 0.01% | +16.7% |
| Q3 2021 | $8,147,000 | -27.9% | 137,444 | +5.6% | 0.01% | -25.0% |
| Q2 2021 | $11,296,000 | +5.5% | 130,154 | +0.3% | 0.01% | 0.0% |
| Q1 2021 | $10,704,000 | +847.3% | 129,822 | +944.7% | 0.01% | +700.0% |
| Q4 2020 | $1,130,000 | – | 12,427 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |